9 torthaí
BACKGROUND OF THE INVENTION
i) Field of the Invention:
The present invention relates to polysulfide compounds and a lipid peroxidation inhibitor containing the polysulfide compounds as an active ingredient.
ii) Description of the Background Art:
It is well known that a variety of vital phenomena
BACKGROUND OF THE INVENTION
i) Field of the Invention
The present invention relates to polysulfide compounds and a lipid peroxidation inhibitor containing the polysulfide compounds as an active ingredient.
ii) Description of the Background Art
It is well known that a variety of vital phenomena
The present invention is concerned with a process for the preparation of pyrrolidine derivatives.
The pyrrolidine derivatives according to the present invention are compounds of the general formula: ##STR3## wherein n is 1, 2 or 3, R.sub.1 and R.sub.2, which may be the same or different, are
This invention relates to a novel isoquinolone compound having medicinal activities including an excellent calcium-antagonistic activity, protective effect of cerebralischemia, anti-cerebral edema activity, protective effect of neuronal damage and tachykinin receptor antagonizing activity.
Recently,
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a method for preventing or treating a brain edema, an intracranial hemorrhage (especially a recurrence of an intracranial hemorrhage and so on) and a cerebral infarction, which comprises administering a
The present invention relates to pharmaceutical agents and more particularly to novel cyclic amine compounds which are effective in treating various symptoms due to brain hypoxia or ischemia, particularly cerebral edema.
The current therapeutic modality for the cerebral edema associated with
The present invention relates to pharmaceutical agents and more particularly to novel cyclic amine compounds which are effective in treating various symptoms due to brain hypoxia or ischemia, particularly cerebral edema.
The current therapeutic modality for the cerebral edema associated with
An present invention relates to pharmaceutical agents and more particularly to novel cyclic amine compounds which are effective in treating various symptoms due to brain hypoxia or ischemia, particularly cerebral edema.
The current therapeutic modality for the cerebral edema associated with
BACKGROUND OF THE INVENTION
The present invention relates to a novel and useful azaazulene derivatives and salts thereof having antiallergic activity and antiinflammatory activity which are based on inhibitory activity against chemical mediator release, 5-lipoxygenase inhibiting activity or relaxing